About 2 results found for searched term "Firmonertinib" (0.131 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9400 | Firmonertinib mesylate | EGFR/HER2 |
| Alflutinib mesylate; AST2818 mesylate | ||
| Firmonertinib (Alflutinib) mesylate is a potent, third generation EGFR inhibitor that targets both EGFR activating mutations and T790M thus leading to tumor growth inhibition. Firmonertinib (AST2818) has the potential for the research of non-small cell lung cancer (NSCLC). | ||
| M40622 | Firmonertinib | EGFR/HER2 |
| Alflutinib; Furmonertinib; AST2818 | ||
| Firmonertinib is an irreversible and selective third-generation EGFR tyrosine kinase inhibitor with central nervous system (CNS) antitumor activity. It can be used in studies related to non-small cell lung cancer (NSCLC). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
